Turn Therapeutics (TTRX) announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders and a forthcoming Founder Blog authored by patient-turned-founder and CEO, Bradley Burnam. The Founder Blog will publicly share ongoing company updates, research insights, and perspectives on Turn’s growth and innovation. Further details about the blog will be announced later this week. The webinar series will provide live discussion covering ongoing programs, strategic milestones, and upcoming developments. The first live session will take place on Wednesday, October 22, 2025, at 2:00 PM ET via webcast.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TTRX:
- Turn Therapeutics appoints Kester to board of directors
- Turn Therapeutics files to sell 7M shares off common stock for holders
- Turn Therapeutics Inc. Common Stock trading resumes
- Turn Therapeutics Inc. Common Stock trading halted, volatility trading pause
- Turn Therapeutics commences trading on Nasdaq